| Accession Number | 0000310158-26-000219 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 12, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP&Pres, Merck Animal Heallth | Common Stock | โ | Aug 10, 2026 | Sale | 20,784 | $130.43 | $2,710,950.65 | 134,703 | Direct | โ | View Details | |
EVP&Pres, Merck Animal Heallth | Common Stock | โ | Aug 11, 2026 | Sale | 7,410 | $131.33 | $973,164.93 | 127,293 | Direct | โ | View Details | |
EVP&Pres, Merck Animal Heallth | Common Stock | โ | Aug 11, 2026 | Sale | 5,427 | $132.35 | $718,261.28 | 121,866 | Direct | โ | View Details | |
EVP&Pres, Merck Animal Heallth | Common Stock | โ | Aug 12, 2026 | Sale | 11,099 | $131.61 | $1,460,770.47 | 110,767 | Direct | โ | View Details | |
EVP&Pres, Merck Animal Heallth | Common Stock | โ | Aug 12, 2026 | Sale | 600 | $132.04 | $79,222.02 | 110,167 | Direct | โ | View Details |